Federal Circuit Affirms Collateral Estoppel Decision Concerning Latisse® (bimatoprost topical solution)

RMMS Secures Invalidity Win on Copaxone® 40 (glatiramer acetate 40 mg/mL)

RMMS Secures Invalidity And Non-Infringement Victories on Patents Related To Axiron® (Testosterone) Transdermal Solution

RMMS Recognized As Second Most Active Firm Representing Defendants in Hatch-Waxman Cases

Federal Circuit Affirms Judgment of Invalidity Concerning OxyContin® (oxycodone extended-release tablets)

RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®)

RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year

RMMS Secures Summary Judgment Against Otsuka Related To Generic Aripiprazole (Abilify®)

Federal Circuit Affirms Judgment of Invalidity Concerning Pulmicort Respules® (budesonide inhalation suspension)

RMMS Secures Second Victory Against Otsuka Related To Generic Aripiprazole (Abilify®)